Cart
sales@molnova.com
CDK9 inhibitor HH1
CAS No. 204188-41-0
CDK9 inhibitor HH1 ( —— )
Catalog No. M13175 CAS No. 204188-41-0
CDK9 inhibitor HH1 is a novel potent, highly selective CDK9 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 76 | Get Quote |
|
| 10MG | 104 | Get Quote |
|
| 25MG | 168 | Get Quote |
|
| 50MG | 246 | Get Quote |
|
| 100MG | 357 | Get Quote |
|
| 500MG | 851 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCDK9 inhibitor HH1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCDK9 inhibitor HH1 is a novel potent, highly selective CDK9 inhibitor.
-
DescriptionCDK9 inhibitor HH1 is a novel potent, highly selective CDK9 inhibitor.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number204188-41-0
-
Formula Weight261.34
-
Molecular FormulaC13H15N3OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)NC1=NC(=C(S1)C(=O)C2=CC=CC=C2)N
-
Chemical Name(4-amino-2-(isopropylamino)thiazol-5-yl)(phenyl)methanone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang H, et al. Cell. 2018 Nov 15;175(5):1244-1258.e26.
molnova catalog
related products
-
NU-6300
NU-6300 is the first covalent, irreversible, ATP-Competitive CDK2 inhibitor with Ki of 6 nM.
-
BMS-509744
BMS-509744 is a potent, selective and ATP competitive Itk inhibitor with an IC50 of 19 nM.
-
Ro-3306
Ro-3306 is a potent, selective, ATP-competitive CDK1 inhibitor with Ki of 35 nM against CDK1/cyclin B1, 10-fold selectivity relative to CDK2/cyclin E and >50-fold relative to CDK4/cyclin D.
